Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23055)

• Formulation Name: Aclidinium Bromide 0.4mg/inh powder
• Company: Astrazeneca

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
LAS-34273	(DMSQ1JV)	Chronic obstructive pulmonary disease	CA22	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid